Status of tryptophan metabolites in different stages of chronic kidney disease of non-diabetc etiology

I. Isakov, V. Čabarkapa, Branislava Srdjenovic-Conic, N. Kladar, B. Ilinčić, D. Burić
{"title":"Status of tryptophan metabolites in different stages of chronic kidney disease of non-diabetc etiology","authors":"I. Isakov, V. Čabarkapa, Branislava Srdjenovic-Conic, N. Kladar, B. Ilinčić, D. Burić","doi":"10.2298/mpns2202005i","DOIUrl":null,"url":null,"abstract":"Introduction. Modification of tryptophan metabolism during the progression of chronic kidney disease may have significant pathophysiological consequences. The aim of this study was to investigate the status of metabolic products of tryptophan, indoxyl sulfate and kynurenine in different stages of chronic kidney disease. Material and Methods. In all participants included in the cross-sectional study (n = 66) with previously diagnosed chronic kidney disease, the parameters of renal function were measured: glomerular filtration rate using radionuclide plasma clearance with 99mTc-labelled diethylene triamine penta-acetate and effective renal plasma flow using 131Ilabeled orthoiodohippuric acid. Plasma concentrations of indoxyl sulfate and kynurenine were measured by high-performance liquid chromatography. Results. A significant difference was observed in the concentrations of both metabolites between the observed groups (Group II - measured glomerular filtration rate - 15 - 60 ml/min/1.73 m?; n = 36 vs. Group I measured glomerular filtration rate > 60 l/ min/1.73 m?; n = 26): indoxyl sulfate 1.07 ? 0.89 vs. 2.44 ? 4.05 ?g/ ml, p < 0.001; kynurenine 3.15 ? 0.22 vs. 3.21 ? 0.17 ?g/ml, p < 0.05. The correlation was statistically significant between glomerular filtration rate and kynurenine - r = -0.38, p = 0.001 and indoxyl sulfate - r = 0.56, p ? 0.001; effective plasma renal flow and kynurenine - r = -0.33, p < 0.05 and indoxyl sulfate - r = 0.46, p ? 0.001. Conclusion. There is a significant difference in the plasma concentrations of indoxyl sulfate and kynurenine in the group of patients with glomerular filtration rate of 15 - 60 ml/min/1.73 m? compared to patients with glomerular filtration rate > 60 ml/min/1.73 m?. In patients with chronic kidney disease, plasma concentrations of both metabolites of tryptophan are inversely correlated with the glomerular filtration rate and effective plasma renal flow.","PeriodicalId":87940,"journal":{"name":"Calcutta medical review","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Calcutta medical review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2298/mpns2202005i","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction. Modification of tryptophan metabolism during the progression of chronic kidney disease may have significant pathophysiological consequences. The aim of this study was to investigate the status of metabolic products of tryptophan, indoxyl sulfate and kynurenine in different stages of chronic kidney disease. Material and Methods. In all participants included in the cross-sectional study (n = 66) with previously diagnosed chronic kidney disease, the parameters of renal function were measured: glomerular filtration rate using radionuclide plasma clearance with 99mTc-labelled diethylene triamine penta-acetate and effective renal plasma flow using 131Ilabeled orthoiodohippuric acid. Plasma concentrations of indoxyl sulfate and kynurenine were measured by high-performance liquid chromatography. Results. A significant difference was observed in the concentrations of both metabolites between the observed groups (Group II - measured glomerular filtration rate - 15 - 60 ml/min/1.73 m?; n = 36 vs. Group I measured glomerular filtration rate > 60 l/ min/1.73 m?; n = 26): indoxyl sulfate 1.07 ? 0.89 vs. 2.44 ? 4.05 ?g/ ml, p < 0.001; kynurenine 3.15 ? 0.22 vs. 3.21 ? 0.17 ?g/ml, p < 0.05. The correlation was statistically significant between glomerular filtration rate and kynurenine - r = -0.38, p = 0.001 and indoxyl sulfate - r = 0.56, p ? 0.001; effective plasma renal flow and kynurenine - r = -0.33, p < 0.05 and indoxyl sulfate - r = 0.46, p ? 0.001. Conclusion. There is a significant difference in the plasma concentrations of indoxyl sulfate and kynurenine in the group of patients with glomerular filtration rate of 15 - 60 ml/min/1.73 m? compared to patients with glomerular filtration rate > 60 ml/min/1.73 m?. In patients with chronic kidney disease, plasma concentrations of both metabolites of tryptophan are inversely correlated with the glomerular filtration rate and effective plasma renal flow.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
色氨酸代谢物在非糖尿病病因慢性肾病不同阶段的地位
介绍。慢性肾脏疾病进展过程中色氨酸代谢的改变可能具有显著的病理生理后果。本研究旨在探讨色氨酸、硫酸吲哚酚和犬尿氨酸在慢性肾脏疾病不同阶段的代谢产物状态。材料和方法。在横断研究中纳入的所有先前诊断为慢性肾脏疾病的参与者(n = 66)中,测量了肾功能参数:使用99mtc标记的放射性核素血浆清除率(肾小球滤过率)和使用131il标记的正碘马尿酸测量有效肾血浆流量。采用高效液相色谱法测定硫酸吲哚酚和犬尿氨酸的血药浓度。结果。观察组之间两种代谢物的浓度有显著差异(II组-测量肾小球滤过率- 15 - 60 ml/min/1.73 m?;n = 36 vs. I组肾小球滤过率> 60 l/ min/1.73 m?N = 26):硫酸吲哚酚1.07 ?0.89 vs 2.44 ?4.05 g/ ml, p < 0.001;犬尿素3.15 ?0.22 vs. 3.21 ?0.17 g/ml, p < 0.05。肾小球滤过率与犬尿氨酸- r = -0.38, p = 0.001,硫酸吲哚酚- r = 0.56, p ?0.001;有效血浆肾流量和犬尿氨酸- r = -0.33, p < 0.05,硫酸吲哚酚- r = 0.46, p ?0.001. 结论。在肾小球滤过率为15 ~ 60ml /min/1.73 m?与肾小球滤过率> 60 ml/min/1.73 m?在慢性肾病患者中,色氨酸两种代谢物的血浆浓度与肾小球滤过率和有效血浆肾流量呈负相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Drug development accelerated by artificial intelligence The artificial intelligence pharma era after “Chat Generative Pre-trained Transformer” Artificial Intelligence-enabled contactless sensing for medical diagnosis Cold-chain transmission, asymptomatic infection, mass screening, vaccine, and modelling: what we know so far for coronavirus disease 2019 control and experience in China A review on COVID-19 transmission, epidemiological features, prevention and vaccination
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1